NDC 51817-171 – Ganciclovir
Ganciclovir Sodium 500 mg/10mL · Injection, Solution · Intravenous
Product NDC51817-171
Product details
- Brand name
- Ganciclovir
- Generic name
- Ganciclovir sodium
- Labeler
- Pharmascience Inc.
- Dosage form
- Injection, Solution
- Route
- Intravenous
- Marketing category
- ANDA · ANDA207645
- Marketed since
- April 24, 2018
- Listing expires
- December 31, 2026
- Pharmacologic class
- Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor; Nucleoside Analog Antiviral
Active ingredients
- Ganciclovir Sodium 500 mg/10mL
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 51817-171-01 | 25 VIAL in 1 CARTON (51817-171-01) / 10 mL in 1 VIAL | Apr 24, 2018 |
| 51817-171-02 | 1 VIAL in 1 CARTON (51817-171-02) / 10 mL in 1 VIAL | Dec 15, 2019 |
Other Ganciclovir products
- 25021-185 Ganciclovir Sodium 50 mg/mL · Injection, Solution · Sagent Pharmaceuticals
- 42023-173 Ganciclovir Sodium 500 mg/10mL · Injection, Powder, Lyophilized, For Solution · Endo USA, Inc.
- 63323-315 Ganciclovir Sodium 500 mg/10mL · Injection, Powder, Lyophilized, For Solution · Fresenius Kabi USA, LLC
- 0143-9299 Ganciclovir Sodium 50 mg/mL · Injection, Powder, Lyophilized, For Solution · Hikma Pharmaceuticals USA Inc.
- 70436-089 Ganciclovir Sodium 500 mg/10mL · Injection, Powder, Lyophilized, For Solution · Slate Run Pharmaceuticals, LLC